Obermatt
See Similar Stocks →

Clariane

PAR:CLARI · FR0010386334
Health Care Providers & ServicesLarge

360

24
EV / EBIT19
Price / Owner Earnings64
Owner Earnings Yield39
Dividend Yield37
Price/Sales91
EV / Gross Profit70
Price/Book95
Return on Capital29
Cash Return on Capital30
Return on Equity12
EBIT Margin41
Gross Profitability31
Cash Conversion98
Accruals91
Owner Earnings Margin31
Sales growth34
Profit Growth42
Long-Term EPS Growth35
Reinvestment71
Price momentum55
Debt load19
Refinancing6
Debt Payback15
Liquidity23
Analyst ratings37
Opinion Changes30
Price Target Upside31
Market mood1
Value Creation10/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Clariane clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryFrance
IndustryHealth Care Providers & Services
SizeLarge
TypePublic Company
ExchangeENXTPA
Founded2003
Employees3,212
Websitekorian.fr
ISINFR0010386334
Last UpdateApr 2, 2026
Indices
CAC All (France)SBF 120 (France)Sound Pay Practices (Europe)
Themes
Women's HealthAssisted LivingHealth DiagnosticsOutpatient CarePsychiatryChronic DiseasesElder CareHealth CareNursing and Residential Care

Description

Analysis

Middle-of-the-road

Clariane SE sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

On valuation, the picture is attractive. The owner-earnings multiple stands at 11.7×; owner earnings: the cash an owner could take out each year.

Growth is moderate; the safety picture is stretched. The company scores 10/20 on our value-creation score: creating some value.

Flags to be aware of: Some accounting patterns deserve a closer look. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
15
2023202420252026

All-time high

71

Jan 2023

All-time low

9

Feb 2024

Average rank

23

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
91
95
100
81
Price/Earnings
28
15
95
79
Price/Book
95
100
97
100
Dividend Yield
37
1
100
96
Value (overall)
75
59
100
95

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Clariane with its peers
Emeis
PAR:EMEIS
15
CountryFrance
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →
Attendo
STO:ATT
75
CountrySweden
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →
Athens Medical Center
ATH:IATR
7
CountryGreece
IndustryHealth Care Providers & Services
SizeSmall
Full Stock Analysis →
LNA Sante
PAR:LNA
45
CountryFrance
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →
Fresenius
GER:FRE
49
CountryGermany
IndustryHealth Care Providers & Services
SizeX-Large
Full Stock Analysis →
Humana
STO:HUM
78
CountrySweden
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →